Dapitan, Josemil D.
HRN: 21-93-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2022
CEFTRIAXONE 1G (VIAL)
09/25/2022
10/01/2022
IV
2g
Q 24H
Multiple Abrasions And Lacerations, Head
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes